Shelved Asset Scout

    2

    Surface de-prioritized pharmaceutical assets and "communication cliffs" for investment and licensing opportunities.

    Free

    14 uses4.0 (2 reviews)

    Works with the AI Agents you already use

    Claude CodeClaude CodeCursorCursorCodex CLICodex CLIMuseMuseDotsDots+21 more

    shelved-asset-scout

    Example session with this skill installed

    Analyze AstraZeneca's recent press releases to identify any high-confidence oncology assets that have experienced a communication cliff or strategic deprioritization since late 2024.

    • Read your context and instructions
    • Compiled the shelved-asset-scout

    CONFIDENCE: HIGH | Asset: AZD-9291 | Company: AstraZeneca
    Strategy: Communication Cliff, Asset Outside Strategy
    Last Mention: 2024-08-15
    Note: Selective silence detected. Total PR volume remains at 12/month, but asset mentions dropped to zero following the oncology portfolio restructuring.

    Connects securely to your tools. The creator never sees your data.

    About this skill

    Pharma De-prioritization Intelligence

    The shelved-asset-scout is a specialized pharmaceutical intelligence skill designed for investors, M&A analysts, and licensing professionals. In the fast-moving biotech landscape, pharmaceutical giants often quietly "shelf" promising assets due to strategic pivots, restructuring, or resource reallocation. This skill surfaces those hidden opportunities by analyzing years of corporate communications.

    What it does

    This tool utilizes a sophisticated multi-phase workflow to detect assets that have been deprioritized or discontinued. It connects to the PharmaceuticIndex MCP server to access a deep corpus of press releases and corporate data. It doesn't just look for explicit keywords like "discontinued"; it uses a Long-Arc Method to identify "communication cliffs"—where an asset mentioned regularly suddenly vanishes from the corporate narrative while overall company activity remains stable.

    Key Features

    • Signal Taxonomy: Categorizes opportunities into five distinct rungs, including EOL corporate-speak, strategy pivots, and out-licensing solicitations.
    • Gap vs. Silence Discrimination: Employs logic to distinguish between actual asset deprioritization and systemic data ingestion artifacts.
    • Semantic Confirmation: Leverages Voyage embeddings to confirm asset absence and detect if a company has pivoted focus to a different therapeutic area.
    • Cadence Calibration: Automatically assesses if a company publishes frequently enough for "silence" to be a statistically significant investment signal.

    Why use this skill?

    Monitoring thousands of pipeline assets manually is impossible. Standard keyword searches often fail because companies use nuanced "corporate-speak" to bury bad news or strategic shifts. This skill automates the detection of multi-year silence arcs, providing a structured, confidence-weighted list of candidates ready for acquisition or licensing outreach.

    • Requires active PharmaceuticIndex subscription
    • Signal detection limited to 2020-present data
    • Keyword search is term-specific (does not support complex boolean nesting)

    How to use

    1. 1

      Connect your agent to the Agensi MCP

      Copy the prompt and paste it into Claude, ChatGPT, Cursor or any agent that supports MCP. It sets up the connection for you. Manual setup

    2. 2

      Sign in to Agensi

      Your agent shows a sign-in link. Sign in and click Allow.

    3. 3

      Ask for what you need

      Your agent loads this skill and uses it on your task. It always asks before any payment.

    Reviews

    4.0
    2 reviews
    5
    1
    4
    0
    3
    1
    2
    0
    1
    0

    This skill has been used 14 times.

    Trust & safety

    Security scan

    Security scan passed 5 months ago

    • Free with an Agensi account

    Permissions

    No special permissions declared or detected

    Listed5 months ago

    What's inside

    Frequently Asked Questions

    This skill identifies 'shelved' pharmaceutical assets by analyzing corporate communication gaps and 'communication cliffs'—instances where a previously highlighted drug candidate disappears from official reports—to surface hidden licensing and M&A opportunities.

    The skill requires the PharmaceuticIndex MCP (Model Context Protocol) server to access its deep corpus of press releases and corporate data, ensuring it has the necessary live data stream to perform its analysis.

    Unlike simple keyword tools, this skill uses a 'Long-Arc Method' to distinguish between temporary news gaps and systemic de-prioritization, using semantic embeddings to confirm if a company’s pivot is strategic or operational.

    Yes, the skill is designed to integrate with any AI agent or platform that supports the Model Context Protocol (MCP), making it compatible with a wide range of enterprise-level research environments.

    Your purchase includes the skill configuration, lifetime access to the analysis workflow, and any future version updates that refine the detection logic and signal taxonomy.

    New in Trading & Investing